American Century Companies Inc Sana Biotechnology, Inc. Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.77 - $6.23 $17,764 - $29,355	-4,712 Reduced 11.61%	35,867 $138,000
Q2 2023 Aug 14, 2023	BUY	$3.22 - $7.53 $71,207 - $166,518	22,114 Added 119.76%	40,579 $241,000
Q1 2023 May 11, 2023	BUY	$3.11 - $4.92 $24,052 - $38,051	7,734 Added 72.07%	18,465 $60,000
Q3 2022 Nov 14, 2022	BUY	$5.58 - $9.04 $59,878 - $97,008	10,731 New	10,731 $64,000

172

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $613M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.